Abstract
Flecainide is a Vaughan-Williams Class 1c antiarrhythmic drug indicated for use in pharmacologic cardioversion and maintenance of sinus rhythm in atrial fibrillation and other supraventricular tachycardias in patients without structural heart disease. However, flecainide has a narrow therapeutic
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
